Global Pigmentation Disorders Treatment Market Set For Rapid Growth, To Reach Around USD 8,479.08 Million By 2024

29-Aug-2018 | Zion Market Research

Zion Market Research has published a new report titled “Pigmentation Disorders Treatment Market by Treatment (Chemical Peels, Microdermabrasion, Topical Drugs, Phototherapy, and Laser Therapy), by Key Disease Indications (Vitiligo, Melasma, Albinism, Solar Lentigines, and Post-inflammatory Hyperpigmentation), and by End-Use (Dermatology Centers, Hospitals, and Aesthetic Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global pigmentation disorders treatment market was valued at approximately USD 5,283.82 million in 2017 and is expected to generate revenue of around USD 8,479.08 million by end of 2024, growing at a CAGR of around 7.02% between 2018 and 2024.

The natural coloring of a human or animal's skin is known as pigmentation. Pigmentation is created due to the deposition of melanin, a pigment produced by melanocytes. The oxidation of tyrosine, an amino acid, results in the production of melanin. Keratinocytes carry melanin to the skin surface. During skin pigmentation disorders, the color of the skin is affected.

Request Sample Request Customization Buy Now

Browse the full "Pigmentation Disorders Treatment Market by Treatment (Chemical Peels, Microdermabrasion, Topical Drugs, Phototherapy, and Laser Therapy), by Key Disease Indications (Vitiligo, Melasma, Albinism, Solar Lentigines, and Post-inflammatory Hyperpigmentation), and by End-Use (Dermatology Centers, Hospitals, and Aesthetic Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/pigmentation-disorders-treatment-market  

Global Pigmentation Disorders Treatment Market

There are two major types of pigmentation disorders: Hyperpigmentation and Hypopigmentation. Hyperpigmentation refers to skin darkening caused by increased levels of melanin. Conditions that can cause hyperpigmentation include pregnancy, Addison's disease, and exposure to sunlight, among others. Hypopigmentation refers to the loss of skin color. Hypopigmentation is majorly caused due to genetic conditions, harsh environmental conditions, or injuries. 

As per the UN estimates, Albinism is present in 1 out of 17,000 to 20,000 people in North America and Europe. In Africa 1 in every 5,000 to 15,000 people have albinism. Around 80% of pregnant women in Mexico and 50-75% of pregnant women in the U.S. are affected by melasma. Prevalence of albinism is high in African nations. Approximately 1 in 5,000 to 15,000 people are estimated to be affected by albinism. 
  
The treatment for pigmentation disorders depends on the pigmentation type. The most common pigmentation disorders are melasma and vitiligo. Melasma is a hyperpigmentary disorder whereas vitiligo is a hypopigmentary disorder. Melasma is treated using a mix of active ingredients that are applied topically. The most effective treatment is a triple combination drug that needs to be applied daily. In addition to this, a broad spectrum sunscreen must also be applied several times a day. Vitiligo is not a very easy disease to treat. Topical treatments are used if the disorder is in a mild form. However, if a large skin surface is affected, ultraviolet therapy is used along with topical treatments.

Factors such as high demand for skin lightening treatments, increasing spending on lifestyle, growing prevalence of skin disorders, and global warming will act as driving factors to the growth of global pigmentation disorders treatment market. Moreover, increasing adoption of smoking in young adults, high disposable income, and growing demand from millennials will boost the global pigmentation disorders treatment market. The rise in research and development activities and growth of medical tourism will act as an opportunity for the market players in the pigmentation disorders treatment market. However, high costs related to cosmetic therapy and lack of awareness regarding skin disorders in developing regions will restrict the growth of global pigmentation disorders treatment market.

The global pigmentation disorders treatment market has been segmented into treatment, key disease indications, end use, and region. The treatment segment has been segmented into chemical peels, microdermabrasion, topical drugs, phototherapy, and laser therapy. Chemical peels segment holds the maximum share of the treatment segment owing to a rise in disposable income. Based on key disease indications, pigmentation disorders treatment market has been segmented into vitiligo, melasma, albinism, solar lentigines, and post-inflammatory hyperpigmentation. Based on end use, pigmentation disorders treatment market has been segmented into dermatology centers, hospitals, and aesthetic clinics.

North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America are key regional segments of global pigmentation disorders treatment market. North America is anticipated to remain the leading region over the forecast period followed by Europe. Demand for pigmentation disorders treatment products was highest in North America especially in the U.S. Asia Pacific is expected to be the highest growing region for pigmentation disorders treatment market during the forecast period. Moreover, the Middle East & Africa and Latin America are also expected to show moderate growth for this market in the years to come.

Some of the key players in the pigmentation disorders treatment market include Allergan, Inc., Episciences, Inc., Bayer AG, La Roche-Posay, Pierre Fabre Laboratories, SkinCeuticals International, Obagi Medical Products Inc., and Alvogen, Inc. among others.

This report segments the global pigmentation disorders treatment market as follows:

Global Pigmentation Disorders Treatment Market: By Treatment

  • Chemical Peels
  • Microdermabrasion
  • Topical Drugs
  • Phototherapy
  • Laser Therapy

Global Pigmentation Disorders Treatment Market: By Key Disease Indications

  • Vitiligo
  • Melasma
  • Albinism
  • Solar Lentigines
  • Post-inflammatory Hyperpigmentation

 Global Pigmentation Disorders Treatment Market: By End-Use

  • Dermatology Centers
  • Hospitals
  • Aesthetic Clinics

Global Pigmentation Disorders Treatment Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Download Brochure
Latest Published Reports

View All Published Reports